SUPPLEMENTARY EXPERIMENTAL PROCEDURES
Mice. Generation of tamoxifen-inducible, forebrain neuron-specific Drp1 flx/flx Cre + mice was described recently (Oettinghaus et al., 2016) . At 8 weeks of age recombination of the floxed loci was induced by tamoxifen injection (Sigma Aldrich, Germany; 1mg twice daily for 5 consecutive days). For genotyping, genomic DNA was isolated from tail tips by proteinase K digestion (Sigma Aldrich, Germany). CreERT2 transgene was amplified using the following primers: 5' GGT TCT CCG TTT GCA CTC AGG A 3', 5' CTG CAT GCA CGG GAC AGC TCT 3', 5' GCT TGC AGG TAC AGG AGG TAG T 3'. Recombination of the Drp1 locus was detected using the following primers: 5' CAG CTG CAC TGG CTT CAT GAC TC 3', 5' TGC CAA GAA TGA TTA CAG TCA GG 3'.
Mutant tau (P301L) and prion-injected (RML) mice have been described elsewhere (Moreno et al., 2013; Radford et al., 2015) . When indicated, mice were treated orally with PERK inhibitor GSK2606414 (50mg/kg, three doses, starting at 10 wpi; Moreno et al., 2013) .
For intraventricular tunicamycin microinjections, mice were anaesthetized by i.p. injection of 10 mg/kg ketamine and 20 mg/kg xylazine. Injections were performed with a 10 µl Hamilton microsyringe as described (Ono et al., 2012 ) using -0.5 mm posterior, -1.0 mm lateral, -2.0 mm inferior relative to bregma as coordinates.
2 µl of 0.1 µg/µl tunicamycin in 1% DMSO or 2 µl vehicle were carefully injected over the course of 2 min and the needle left in place for 5 min before retraction. Following scalp suture mice were monitored until recovery from anesthesia. After 48h, mice were sacrificed, their hippocampi dissected and plasma collected (between 9 and 10 AM).
TUDCA treatment was initiated at day 1 PTI. Mice were fed 0.4% TUDCA-supplemented chow (chow: ssniff, Germany; TUDCA: Merck, UK) for 7 weeks.
All experiments were performed under specific pathogen-free conditions, in accordance with Swiss animal protection legislation and with approval of the Basel Veterinary Committee for Animal Care (permits 2393, 23288).
Western Blot. Lysates of perfused mouse brains were analyzed as previously described (Oettinghaus et al., 2016 Histology and immunohistochemistry. Following transcardial formaldehyde perfusion of anaesthetized mice, histological assessment was performed using previously described protocols (Oettinghaus et al., 2016) .
In brief, coronal hippocampal sections (4 µm) were prepared from formalin-fixed, paraffin-embedded (FFPE)
wildtype mouse brain and hematoxylin-eosin stained using standard protocols. In addition, FFPE sections were subjected to immunohistochemistry using anti-GFAP (DAKO; 1:500), anti-NeuN (Chemicon; 1:200), and antiIba1 (Wako; 1:3000); secondary antibody was anti-rabbit IgG (Vector; ImmPRESS Reagent Kit). All immunohistochemical stains were performed on an automated Ventana immunostaining instrument using prediluted antibodies (Ventana Medical Systems Inc.). For quantification of Fgf21 signal, Fgf21-positive area/ total area was employed within the CA1 region.
Briefly, images were thresholded and analyzed with the "analyze particles" function on ImageJ within an indicated ROI corresponding to the CA1 region.
Ultrastructural analyses. Transmission electron microscopy was performed as previously described (Oettinghaus et al., 2016 ) using a Phillips CM100 transmission electron microscope. ELISA and other kits. Blood was collected between 9 and 10 AM in EDTA-coated tubes and hormone levels were detected by ELISA from plasma (FGF21: BioVendor, RD291108200R). Total amino acids were measured on hippocampi, cortices and cerebella 10 weeks PTI with the L-Amino Acid Quantitation Kit (MAK002, Sigma Aldrich, Germany) according to manufacturer's instructions.
Proteomics. In Fig. S2B , P-values denote likelihood of protein group being a random sample of the total population of detected proteins (Fisher's exact test). Reference dataset was obtained from (Han et al., 2013) . 
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